Bristol Gives Up On Adjuvant Melanoma For Opdualag With Failed Trial

 
• By Joseph Haas
  
Bristol Myers Squibb fails a Phase III study with Opdualag in adjuvant melanoma • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Clinical Trials

More from Therapy Areas